Free Trial

M&T Bank Corp Acquires 3,073 Shares of HCA Healthcare, Inc. $HCA

HCA Healthcare logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • M&T Bank Corp boosted its stake in HCA by 35.9% in Q4, acquiring 3,073 shares to hold 11,623 shares worth about $5.43 million.
  • HCA reported Q1 EPS of $7.15 (missing the $7.19 consensus by $0.04) on $19.11 billion in revenue (up 4.3% year‑over‑year) and set FY2026 EPS guidance of 29.10–31.50 with analysts forecasting ~30.05 EPS.
  • The company announced a quarterly dividend of $0.78 payable June 30 (annualized yield ~0.7%), while insiders sold roughly 13,714 shares (~$7.05 million) over the past 90 days, including large sales by senior executives.
  • MarketBeat previews the top five stocks to own by June 1st.

M&T Bank Corp grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 35.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,623 shares of the company's stock after acquiring an additional 3,073 shares during the quarter. M&T Bank Corp's holdings in HCA Healthcare were worth $5,427,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. Sovran Advisors LLC boosted its position in shares of HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company's stock valued at $1,063,000 after acquiring an additional 22 shares during the period. Centerpoint Advisors LLC boosted its position in shares of HCA Healthcare by 11.0% in the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company's stock valued at $95,000 after acquiring an additional 22 shares during the period. Cary Street Partners Financial LLC boosted its position in shares of HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company's stock valued at $251,000 after acquiring an additional 22 shares during the period. Angeles Wealth Management LLC lifted its position in HCA Healthcare by 2.4% in the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company's stock worth $432,000 after purchasing an additional 24 shares during the period. Finally, One Capital Management LLC lifted its position in HCA Healthcare by 1.1% in the third quarter. One Capital Management LLC now owns 2,250 shares of the company's stock worth $959,000 after purchasing an additional 24 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $430.45 on Thursday. The stock has a market cap of $95.49 billion, a PE ratio of 14.80, a PEG ratio of 1.36 and a beta of 1.18. The business has a fifty day moving average of $493.48 and a two-hundred day moving average of $486.55. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the previous year, the business posted $6.45 earnings per share. The firm's revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts predict that HCA Healthcare, Inc. will post 30.05 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is 10.73%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. TD Cowen reduced their target price on HCA Healthcare from $561.00 to $500.00 and set a "buy" rating for the company in a research report on Monday, April 27th. The Goldman Sachs Group raised their target price on HCA Healthcare from $520.00 to $558.00 and gave the stock a "buy" rating in a research report on Wednesday, January 28th. Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. Argus reduced their target price on HCA Healthcare from $560.00 to $500.00 and set a "buy" rating for the company in a research report on Monday. Finally, UBS Group lifted their price objective on HCA Healthcare from $598.00 to $635.00 and gave the company a "buy" rating in a report on Monday, February 23rd. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $517.82.

Get Our Latest Research Report on HCA

Insider Activity

In other news, SVP Jennifer Berres sold 8,020 shares of the firm's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares of the company's stock, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 13,714 shares of company stock worth $7,050,460. 1.50% of the stock is owned by corporate insiders.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.

These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines